.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Baxter
McKinsey
Deloitte
Federal Trade Commission
QuintilesIMS
Argus Health
Cantor Fitzgerald
UBS
Queensland Health

Generated: November 21, 2017

DrugPatentWatch Database Preview

VALIUM Drug Profile

« Back to Dashboard

Which patents cover Valium, and what generic Valium alternatives are available?

Valium is a drug marketed by Roche and is included in two NDAs.

The generic ingredient in VALIUM is diazepam. There are eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
VALIUM
diazepam
TABLET;ORAL013263-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Roche
VALIUM
diazepam
INJECTABLE;INJECTION016087-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Roche
VALIUM
diazepam
TABLET;ORAL013263-004Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Roche
VALIUM
diazepam
TABLET;ORAL013263-006Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VALIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
VALIUM
diazepam
TABLET;ORAL013263-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Roche
VALIUM
diazepam
INJECTABLE;INJECTION016087-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Roche
VALIUM
diazepam
TABLET;ORAL013263-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Roche
VALIUM
diazepam
TABLET;ORAL013263-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Fish and Richardson
AstraZeneca
Julphar
Novartis
Cipla
Daiichi Sankyo
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot